Hepatitis B Reactivation with Novel Agents in Non-Hodgkin’s Lymphoma and Prevention Strategies

Hepatitis B virus (HBV) infection remains an endemic disease in most parts of the world despite available prophylactic vaccines. Non-Hodgkin’s lymphoma is the most common hematological malignancy, and certain patients undergoing therapy are at increased risk of HBV reactivation. Rituximab, a monoclo...

Descripción completa

Detalles Bibliográficos
Autores principales: Ozoya, Oluwatobi O., Sokol, Lubomir, Dalia, Samir
Formato: Online Artículo Texto
Lenguaje:English
Publicado: XIA & HE Publishing Inc. 2016
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4913070/
https://www.ncbi.nlm.nih.gov/pubmed/27350944
http://dx.doi.org/10.14218/JCTH.2016.00005

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4913070/
https://www.ncbi.nlm.nih.gov/pubmed/27350944
http://dx.doi.org/10.14218/JCTH.2016.00005

Ejemplares similares